Angiotensin II, adhesion, and cardiac fibrosis

Cardiovascular Research

Volumn 46, Issue 2, 2000, Pages 264-268

  Schnee, Janet M ^a   Hsueh, Willa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin; Extracellular matrix; Fibrosis; Hypertrophy

Indexed keywords

ANGIOTENSIN; CELL ADHESION MOLECULE; INTEGRIN; OSTEOPONTIN;

EXTRACELLULAR MATRIX; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0034032576     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00044-4     Document Type: Review

References (46)

1. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 327:1992;669-677.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
4. Effect of ramipril on the mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
5. Cohn J.N., Johnson G., Zeische S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
6. Falkenhahn M., Gohlke P., Paul M., Stoll M., Unger T. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. J Cardiovasc Pharmacol. 24:(Suppl 2):1994;S6-S13.
7. Pitt B., Martinez F.A., Meurers G.G., et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly study ELITE). Lancet. 349:1997;747-752.
8. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 96:1997;4065-4082.
9. Weber K.T., Brilla C.G. Pathologic hypertrophy and cardiac interstitium. Circulation. 83:1991;1849-1865.
10. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 73:1993;413-423.
11. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
12. Weber K.T., Brilla C.G., Janicki J.S. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 27:1993;341-348.
13. Schorb W., Booz G.W., Dostal D.E., Conrad K.M., Chang K.C., Baker K.M. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 72:1993;1245-1254.
14. Crawford D.C., Chobanian A.V., Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res. 74:(4):1994;727-739.
15. Doering C.W., Jalil J.E., Janicki J.S., Pick R., Shroff S.G., Weber K.T. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 22:1988;686-695.
16. Jalil J.E., Doering C.W., Janicki J.S., Pick R., Shroff S.G., Weber K.T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 64:1989;1041-1050.
17. Sabbah H.N., Sharov V.G., Lesch M., Goldstein S. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem. 147:1995;29-34.
18. Giancotti F.G. Integrin signaling: specificity and control of cell survival and cycle progression. Curr Opin Cell Biol. 9:(5):1997;691-700.
19. Giancotti F.G., Ruoslahti E. Integrin signaling. Science. 285:1999;1028-1032.
20. Sheetz M.P., Felsenfeld D.P., Galbraith C.G. Cell migration: regulation of force on extracellular-matrix:integrin complexes. Trends Cell Biol. 8:(2):1998;51-54.
21. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signaling: the shape of things to come. Biochem J. 339:1999;481-488.
22. Soldi R., Mitola S., Strasly M., Defiilippi P., Tarone G., Bussolino F. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18:(4):1999;882-892.
23. Schneller M., Vuori K., Rouskahti E. αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J. 16:(18):1997;5600-5607.
24. Guilherme A., Torres K., Czech M.P. Cross-talk between insulin receptor and integrin α5β1 signaling pathways. J Biol Chem. 273:(36):1998;22899-22903.
25. Li J., Lin M.L., Wiepz G.J., Guadarrama A.G., Bertics P.J. Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor. J Biol Chem. 274:(16):1999;11209-11209.
26. Shakibaei M., John T., Souza P., Rahmanzadeh R., Merker H. Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem J. 342:1999;615-623.
27. Zheng B., Clemmons D.R. Blocking ligand occupancy of the αvβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA. 95:1998;11217-11222.
28. Zhu X., Ohtsubo M., Bohmer R.M., Roberts J.M., Assoian R.K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol. 133:(2):1996;391-403.
29. Roovers K., Davey G., Zhu X., Bottazzi M.E., Assoian R.K. α5β1 integrin controls cyclin d1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell. 10:(10):1999;3197-3204.
30. Carvalho R.S., Schaffer J.L., Gerstenfeld L.C. Osteoblasts induce osteopontin expression in response to attachment on fibronectin: demonstration of a common role for integrin receptors in the signal transduction processes of cell attachment and mechanical stimulation. J Cell Biochem. 170:(3):1998;376-390.
31. Ivaska J., Reunanen H., Westermarck J., Koivisto L., Kahari V.M., Heino J. Integrin α2β1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the α2 cytoplasmic tail. J Cell Biol. 147:(2):1999;401-416.
32. Kawano H., Cody R.J., Graf K., et al. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. Hypertension. 35:(1 Part 2):2000;273-279.
33. Kawano H, Do YS, Kawano Y et al, Angiotensin II had multiple pro-fibrotic effects in human cardiac fibroblasts. Circulation (in press).
34. Rodan G. Osteopontin overview. Ann NY Acad Sci. 760:1995;1-5.
35. Liaw L., Skinner M.P., Raines E.W., et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: Role of αvβ3 in smooth muscle migration to osteopontin. J Clin Invest. 95:(2):1995;713-724.
36. Nagasaki T., Ishimura E., Shioi A., et al. Osteopontin gene expression and protein synthesis in cultured rat mesangial cells. Biochem Biophys Res Commun. 233:(1):1997;81-85.
37. Malyankar U.M., Almeida M., Johnson R.J., Pichler R.H., Giachelli C.M. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int. 51:(6):1997;1766-1773.
38. Sodek J., Chen J., Nagata T., et al. Regulation of osteopontin expression in osteoblasts. Ann NY Acad Sci. 760:1995;223-241.
39. Liaw L., Almeida M., Hart C.E., Schwartz S.M., Giachelli C.M. III. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 72:1994;214-224.
40. Giachelli C.M., Bae N., Almeida M., Denhardt D.T., Alpers C.E., Schwartz S.M. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 92:1993;1686-1696.
41. Ophascharoensuk V., Giachelli C.M., Gordon K., Hughes J., et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 56:(2):1999;571-580.
42. Graf K., Do Y.S., Ashizawa N., et al. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation. 96:1997;3063-3071.
43. Ashizawa N., Graf K., Do Y.S., et al. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest. 98:(10):1996;2218-2227.
44. Hsueh W.A., Law R.E., Do Y.S. Integrins, adhesion, and cardiac remodeling. Hypertension. 31:(Part 2):1998;176-180.
45. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 331:(19):1994;1286-1292.
46. Yamamoto K., Saito H. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int J Hematol. 68:(4):1998;371-385.